Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.

Latest updates to the Incyte Press Releases page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a new press release entry 'Incyte to Present at Upcoming Investor Conferences' dated February 17, 2026 to the press releases page.SummaryDifference0.5%

- Check18 days agoChange DetectedDifference15%

- Check26 days agoChange DetectedAdded a new press release dated January 30, 2026: Incyte announces a positive CHMP opinion for Zynyz (retifanlimab) for first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC).SummaryDifference0.7%

- Check33 days agoChange DetectedA new press release entry 'Incyte to Report Fourth Quarter and Year-End 2025 Financial Results' dated January 27, 2026 has been added to the Press Releases page.SummaryDifference0.7%

- Check55 days agoChange DetectedAdded the 2026 press release dated January 5, 2026 and the © 2012-2026 notice. Removed older 2025 content and pagination/navigation to streamline the Press Releases listing.SummaryDifference11%

- Check69 days agoChange DetectedAdded two December 22, 2025 press releases about Minjuvi approval in Japan and Zynyz approval for first-line advanced anal cancer, plus a December 18, 2025 entry about an upcoming investor conference. Deleted the December 1, 2025 appointment of Richard Hoffman as EVP and GC, and the November 17, 2025 CHMP opinion and the November 19, 2025 investor-conferences item from the list.SummaryDifference6%

Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.